ISABELLE LOUIS: Open Payments
NPI 1497530448 · WEST HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,018 in 96 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $217 · 2025 $3,018
Food & beverage: $3,018
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $419 |
| Xeris Pharmaceuticals, Inc. | 12 | $348 |
| Ascendis Pharma Endocrinology Inc | 9 | $337 |
| Insulet Corporation | 12 | $295 |
| Abbott Laboratories | 8 | $280 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $260 |
| Amgen Inc. | 10 | $222 |
| Lilly USA, LLC | 4 | $209 |
| Amneal Pharmaceuticals LLC | 6 | $126 |
| Medtronic, Inc. | 3 | $106 |
Products named: Yorvipath, Wegovy, Omnipod, FREESTYLE LIBRE 3, RECORLEV, JARDIANCE, TEPEZZA, UNITHROID.
Industry payments across CT — which companies pay providers there.
